NCT02976610 is a NA clinical trial of Hemolysis Point-of-Care test in Hemolysis, sponsored by Hemcheck Sweden AB.

Who is sponsoring NCT02976610?

NCT02976610 is sponsored by Hemcheck Sweden AB.

What drugs are being tested in NCT02976610?

Interventions in NCT02976610: Hemolysis Point-of-Care test.

What condition does NCT02976610 study?

NCT02976610 studies Hemolysis, Blood Specimen Collection.

Is NCT02976610 still recruiting?

NCT02976610 is currently completed. Last updated 12 June 2017.

Last reviewed 2017-06-12 · How we verify

NCT02976610

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Study of a Novel Hemolysis Point of Care Test at an Emergency Department.

Completed NA Last updated 12 June 2017

What this trial tests

NA trial testing Hemolysis Point-of-Care test in Hemolysis in 1,671 participants. Completed in 5 May 2017.

Timeline

1 December 2016

Primary endpoint
5 May 2017

5 May 2017

Quick facts

Lead sponsor	Hemcheck Sweden AB
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	1,671
Start date	1 December 2016
Primary completion	5 May 2017
Estimated completion	5 May 2017
Sites	1 location across Sweden

Drugs / interventions tested

Hemolysis Point-of-Care test

Conditions studied

Hemolysis — all drugs for Hemolysis →
Blood Specimen Collection — all drugs for Blood Specimen Collection →

Sponsor

Hemcheck Sweden AB

Who can join

18 and older, any sex, with Hemolysis or Blood Specimen Collection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the outcome of hemolysis frequency when a hemolysis point of care test is introduced in an emergency department.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hemolysis

Currently open trials in the same condition.

NCT07345091 — Feasibility Performance Study of ABL90 FLEX PLUS HEM · recruiting
NCT06721455 — Modeling Blood Management and Hemolytic Risk in Pediatric Heart Surgery · recruiting
NCT06861816 — Ventilatory Functions and Physical Intolerance in ESRD Adolescents: Response to Program of Walking With Dogs · NA · recruiting
NCT06806891 — Restless Leg Syndrome: Is There a Response to Buddhist Walking Meditation in Hemodialysis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02976610 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hemcheck Sweden AB
Last refreshed: 12 June 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02976610.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing